• 1.

    EMPA-KIDNEY Collaborative Group; Herrington WG, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med, published online ahead of print November 4, 2022. doi: 10.1056/NEJMoa2204233

    • PubMed
    • Search Google Scholar
    • Export Citation

Empagliflozin Improves Outcomes in CKD at Risk of Progression

Restricted access
Save